Daiichi-Sankyo

Controversy in FLT3-ITD AML: Is the Optimal Duration of Maintenance Therapy Clearly Defined?

COSTEM Congress 2026
Friday 2nd October, 13:45–14:45 CEST
Berlin, Germany

Thank you for attending our satellite symposium

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Evaluation Questions

Please take a few minutes to answer this questionnaire. Your answers are important to us and will assist us in evaluating the success of this programme and planning future events.

How would you evaluate the following?

Satellite symposium overall*
Content of the debate*
Panel discussion*

Please evaluate the individual debates:

Is The Optimal Duration of Maintenance Therapy Clearly Defined?

Prof. Federico Lussana – YES

The debate was informative and communicated clearly*
The content will impact my practice/area of research*

Dr. Pramila Krishnamurthy – NO

The debate was informative and communicated clearly*
The content will impact my practice/area of research*

MED-EU-QUI-00380 | Date of approval: September 2026